<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To describe the effects of treatment with the selective <z:chebi fb="19" ids="28790">serotonin</z:chebi> reuptake inhibitor <z:chebi fb="0" ids="5138">fluvoxamine</z:chebi> on three patients with advanced <z:hpo ids='HP_0000726'>dementia</z:hpo> who developed a stereotypic <z:hpo ids='HP_0100022'>movement disorder</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>CASE SUMMARY: Three patients in a skilled nursing facility were referred by their primary physicians for psychiatric consultation to assist with the management of <z:hpo ids='HP_0000733'>stereotypic behaviors</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The patients received a standard medical, neurologic, and psychiatric workup for <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Two of the patients were diagnosed with <z:hpo ids='HP_0000726'>dementia</z:hpo> of the Alzheimer type and the other patient was diagnosed with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> three patients were started on <z:chebi fb="0" ids="5138">fluvoxamine</z:chebi> 25 mg/d; behaviors were monitored daily by the nursing staff and their primary care physicians and weekly by their psychiatrist using the <z:mp ids='MP_0003492'>Abnormal Involuntary Movement</z:mp> Scales </plain></SENT>
<SENT sid="5" pm="."><plain>The dosage was titrated upward weekly to a maximum dosage of 150 mg/d </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Two patients showed complete resolution of their <z:hpo ids='HP_0000733'>stereotypic behaviors</z:hpo> by week 6 </plain></SENT>
<SENT sid="7" pm="."><plain>The third patient showed noticeable improvement with some residual movements after 8 weeks of treatment </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: <z:chebi fb="0" ids="5138">Fluvoxamine</z:chebi> appeared effective in the control of <z:hpo ids='HP_0000733'>stereotypic behaviors</z:hpo> in three patients with advanced <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
</text></document>